The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...